Today's roundup brings together new research and personal stories that highlight how varied the GLP-1 experience has become. A clinical trial suggests diet alone can rival medication for weight loss, while a well known actor speaks publicly for the first time about her own use of these drugs. Elsewhere, a writer describes the financial strain of paying for treatment, and a retail report points to a shift in how users shop for food. Together, these stories show the medical, personal, and economic sides of GLP-1 use.
The trial, published in JAMA Network Open, followed 224 overweight adults with an average age of 54 for 16 weeks. Researchers from a group of U.S. universities, including the University of Utah, compared a low-fat vegan diet against the injectable medication semaglutide and found the two approaches produced comparable weight loss. For readers who cannot or do not want to use an injectable drug, this suggests that a structured dietary change may offer a similar outcome. Anyone considering either path should discuss the specifics with a doctor, since the study focused on averages across a group rather than individual results.
Chrissy Metz, known for her role on 'This Is Us,' spoke publicly for the first time about her own use of a GLP-1 medication. Her decision to share this detail adds a recognizable voice to the wider conversation about who uses these drugs and why. Public figures disclosing their own treatment can shift how open other people feel about discussing their own choices. Metz did not frame the decision as something to hide, which may make the topic easier for others to raise with their own doctors or families.
Metz also admitted that she was skeptical before she decided to try a GLP-1 drug. That hesitation is common among people weighing whether to start this kind of medication, and hearing it from someone in the public eye may reassure readers who feel the same uncertainty. Her willingness to describe the doubt, rather than only the decision, gives a fuller picture of what leads someone toward treatment. Readers who share similar concerns may find it useful to weigh their own hesitations against the outcomes reported by others.
One writer described spending most of her disposable income on a GLP-1 medication, a cost her spouse does not fully understand. She explained that the decision is about more than body image, pointing to reasons that go beyond appearance alone. The disagreement highlights a financial and personal strain that can arise inside a household when one partner is paying for ongoing treatment. Couples facing a similar gap in understanding may benefit from talking openly about the reasons behind the expense, rather than letting cost alone define the conversation.
A report from Grocery Dive found that people using GLP-1 medications are buying fewer groceries overall. The shift points to a broader change in spending habits tied to appetite changes that come with these drugs. Retailers and grocery companies are watching this trend closely, since it affects how much food shoppers plan to buy and how often. For readers on a GLP-1, this may explain a change in grocery bills or shopping patterns they have already noticed.
These stories together suggest that GLP-1 use is not a single path but a set of individual decisions shaped by cost, skepticism, and results. Readers weighing their own next step may want to look at both the clinical data and the personal accounts before deciding what fits their situation. Talking with a doctor about the specific numbers behind any diet or medication choice remains the most reliable way to judge what will work for a given person.
Key details
A low-fat vegan diet matched semaglutide's weight loss in a 16-week trial.
Chrissy Metz publicly shared for the first time that she is using a GLP-1 medication.
Metz admitted she was initially skeptical before deciding to try a GLP-1 drug.
A writer spends heavily on a GLP-1, and her spouse doesn't understand why.
GLP-1 users are buying fewer groceries, according to a report from Grocery Dive.
Sources
Chrissy Metz reveals she’s taking a GLP-1 drug — NBC10 Boston
Chrissy Metz reveals she’s taking a GLP-1 drug - but she was skeptical at first — NBC News
I'm Spending Most of My Disposable Income on a GLP-1. My Spouse Doesn't Get It. — Slate
GLP-1 users aren’t buying as many groceries, Grocery Dive said — AL.com